| Profile | GDS4304 / 201922_at |
| Title | ATP effect on acute myeloid leukemia lymphoblasts |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM766225 | untreated AML 2B blasts | 3360.95 | 99 |
| GSM766227 | untreated AML 3 blasts | 5047.32 | 99 |
| GSM766229 | untreated AML 4B blasts | 3803.52 | 99 |
| GSM766226 | ATP-treated AML 2B blasts | 3825.37 | 99 |
| GSM766228 | ATP-treated AML 3 blasts | 4227.87 | 99 |
| GSM766230 | ATP-treated AML 4B blasts | 3758.14 | 99 |
| GSM766231 | untreated AML 6B blasts | 1892.48 | 97 |
| GSM766233 | untreated AML 7C blasts | 5160.71 | 99 |
| GSM766245 | untreated AML 13 blasts | 2847.03 | 98 |
| GSM766232 | ATP-treated AML 6B blasts | 1718.18 | 97 |
| GSM766234 | ATP-treated AML 7C blasts | 4140.88 | 99 |
| GSM766246 | ATP-treated AML 13 blasts | 2219.35 | 98 |
| GSM766235 | untreated AML 8 blasts | 2199.96 | 98 |
| GSM766237 | untreated AML 9 blasts | 2750.8 | 98 |
| GSM766247 | untreated AML 14 blasts | 2325.57 | 98 |
| GSM766236 | ATP-treated AML 8 blasts | 2249.68 | 98 |
| GSM766238 | ATP-treated AML 9 blasts | 2629.54 | 98 |
| GSM766248 | ATP-treated AML 14 blasts | 1758.04 | 97 |
| GSM766239 | untreated AML 10 blasts | 3228.38 | 98 |
| GSM766241 | untreated AML 11 blasts | 2242.15 | 98 |
| GSM766243 | untreated AML 12 blasts | 2507.74 | 98 |
| GSM766240 | ATP-treated AML 10 blasts | 2899.52 | 98 |
| GSM766242 | ATP-treated AML 11 blasts | 2776.07 | 98 |
| GSM766244 | ATP-treated AML 12 blasts | 2387.53 | 98 |